These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32770447)

  • 41. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease.
    Montine TJ; Monsell SE; Beach TG; Bigio EH; Bu Y; Cairns NJ; Frosch M; Henriksen J; Kofler J; Kukull WA; Lee EB; Nelson PT; Schantz AM; Schneider JA; Sonnen JA; Trojanowski JQ; Vinters HV; Zhou XH; Hyman BT
    Alzheimers Dement; 2016 Feb; 12(2):164-169. PubMed ID: 26327235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease.
    Visser PJ; Vos S; van Rossum I; Scheltens P
    Alzheimers Dement; 2012 Nov; 8(6):560-3. PubMed ID: 23102126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantifying cognitive resilience in Alzheimer's Disease: The Alzheimer's Disease Cognitive Resilience Score.
    Yao T; Sweeney E; Nagorski J; Shulman JM; Allen GI
    PLoS One; 2020; 15(11):e0241707. PubMed ID: 33152028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Which medical and social decision topics are important after early diagnosis of Alzheimer's Disease from the perspectives of people with Alzheimer's Disease, spouses and professionals?
    Bronner K; Perneczky R; McCabe R; Kurz A; Hamann J
    BMC Res Notes; 2016 Mar; 9():149. PubMed ID: 26956520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Toward Preclinical Trials for Alzheimer's Disease].
    Miyagawa T; Iwatsubo T
    Brain Nerve; 2017 Jul; 69(7):711-722. PubMed ID: 28739984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alzheimer's disease: The next frontier-Special Report 2017.
    Karlawish J; Jack CR; Rocca WA; Snyder HM; Carrillo MC
    Alzheimers Dement; 2017 Apr; 13(4):374-380. PubMed ID: 28314660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.
    Knopman DS; Haeberlein SB; Carrillo MC; Hendrix JA; Kerchner G; Margolin R; Maruff P; Miller DS; Tong G; Tome MB; Murray ME; Nelson PT; Sano M; Mattsson N; Sultzer DL; Montine TJ; Jack CR; Kolb H; Petersen RC; Vemuri P; Canniere MZ; Schneider JA; Resnick SM; Romano G; van Harten AC; Wolk DA; Bain LJ; Siemers E
    Alzheimers Dement; 2018 Apr; 14(4):563-575. PubMed ID: 29653607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease.
    Teipel SJ; Sabri O; Grothe M; Barthel H; Prvulovic D; Buerger K; Bokde AL; Ewers M; Hoffmann W; Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S329-47. PubMed ID: 22735677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Addition of a frequency-weighted score to the Behavioral Pathology in Alzheimer's Disease Rating Scale: the BEHAVE-AD-FW: methodology and reliability.
    Monteiro IM; Boksay I; Auer SR; Torossian C; Ferris SH; Reisberg B
    Eur Psychiatry; 2001 Jan; 16 Suppl 1():5s-24s. PubMed ID: 11520474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Alzheimer's Disease Cooperative Study (ADCS)].
    Mori H; Ikeuchi T
    Brain Nerve; 2014 Jun; 66(6):691-8. PubMed ID: 24899351
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
    Swerdlow RH
    Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease.
    Relkin NR; Kwon YJ; Tsai J; Gandy S
    Ann N Y Acad Sci; 1996 Dec; 802():149-76. PubMed ID: 8993494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing cognition and function in Alzheimer's disease clinical trials: do we have the right tools?
    Snyder PJ; Kahle-Wrobleski K; Brannan S; Miller DS; Schindler RJ; DeSanti S; Ryan JM; Morrison G; Grundman M; Chandler J; Caselli RJ; Isaac M; Bain L; Carrillo MC
    Alzheimers Dement; 2014 Nov; 10(6):853-60. PubMed ID: 25458309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades.
    Molinuevo JL; Minguillon C; Rami L; Gispert JD
    J Alzheimers Dis; 2018; 62(3):1067-1077. PubMed ID: 29562531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concurrent Alzheimer's pathology in patients with clinical normal pressure hydrocephalus: correlation of high-volume lumbar puncture results, cortical brain biopsies, and outcomes.
    Pomeraniec IJ; Bond AE; Lopes MB; Jane JA
    J Neurosurg; 2016 Feb; 124(2):382-8. PubMed ID: 26339853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.
    Neurobiol Aging; 1997; 18(4 Suppl):S1-2. PubMed ID: 9330978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alzheimer's/Vascular Spectrum Dementia: Classification in Addition to Diagnosis.
    Emrani S; Lamar M; Price CC; Wasserman V; Matusz E; Au R; Swenson R; Nagele R; Heilman KM; Libon DJ
    J Alzheimers Dis; 2020; 73(1):63-71. PubMed ID: 31815693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.